These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Methodologies for anti-HLA antibody screening in patients awaiting kidney transplant: a comparative study. Minucci PB; Grimaldi V; Casamassimi A; Cacciatore F; Sommese L; Picascia A; Resse M; Sabia C; Russo A; Napoli C Exp Clin Transplant; 2011 Dec; 9(6):381-6. PubMed ID: 22142045 [TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation. Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767 [TBL] [Abstract][Full Text] [Related]
7. Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay. Visentin J; Bachelet T; Borg C; Franchini N; Nong T; Lee JH; Couzi L; Merville P; Guidicelli G; Taupin JL Transplantation; 2017 Mar; 101(3):624-630. PubMed ID: 27336398 [TBL] [Abstract][Full Text] [Related]
8. Antibody monitoring system to support the single-antigen Luminex assay in donor-specific antibody detection. Hwang HS; Sun IO; Yoon HE; Choi BS; Oh EJ; Kim JI; Moon IS; Kim YS; Yang CW Hum Immunol; 2012 Apr; 73(4):370-5. PubMed ID: 22342452 [TBL] [Abstract][Full Text] [Related]
9. The Most Common HLA Alleles and Anti-HLA Antibodies to Know for Virtual Cross-Match. Baştürk B; Kantaroğlu B; Kavuzlu M; Sarıtürk Ç Exp Clin Transplant; 2016 Nov; 14(Suppl 3):53-55. PubMed ID: 27805512 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools. Eng HS; Bennett G; Bardy P; Coghlan P; Russ GR; Coates PT Hum Immunol; 2009 Aug; 70(8):595-9. PubMed ID: 19527759 [TBL] [Abstract][Full Text] [Related]
11. Is flow cytometry crossmatch analysis using sera with different dilutions important for pretransplant analysis? A case report. Sağıroğlu T; Tozkır H; Kılıçarslan-Ayna T; Yağcı MA; Sezer A; Carin M Transplant Proc; 2012; 44(6):1767-9. PubMed ID: 22841268 [TBL] [Abstract][Full Text] [Related]
12. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. Aubert V; Venetz JP; Pantaleo G; Pascual M Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474 [TBL] [Abstract][Full Text] [Related]
13. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization. Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237 [TBL] [Abstract][Full Text] [Related]
14. Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation. Bosch A; Llorente S; Diaz JA; Salgado G; López M; Boix F; López-Hernández R; González-Soriano MJ; Campillo JA; Moya-Quiles MR; Perez-Lopez N; Minguela A; Jimeno L; Alvarez-López MR; Muro M Hum Immunol; 2012 May; 73(5):522-5. PubMed ID: 22425738 [TBL] [Abstract][Full Text] [Related]